Largest ever protein study set to revolutionise cancer and dementia tests - Tens of millions of pounds in investment is being ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
But as the year comes to a close, experts are reflecting on some of the hopeful advances in diagnosis, treatment and risk ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea ... but are predominately used to help meet the local financial requirements ...